Form 4: Integra LifeSciences Executive Mosebrook Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences, reports acquisition and disposal of common stock on July 1, 2024.
Summary
- On July 1, 2024, Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences Holdings Corp, reported changes in beneficial ownership of the company's common stock.
- Mosebrook acquired 10,356 shares of common stock.
- Mosebrook disposed of 0 shares of common stock at $0.
- Following the reported transactions, Mosebrook beneficially owns 37,279 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to changes in beneficial ownership by a company insider, as required by the SEC. It provides transparency to the market regarding the trading activities of company executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of transaction: acquisition and disposal of common stock |
| 07/02/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.